4.6 Article

Transcriptional regulation of CCL20 expression

Journal

MICROBES AND INFECTION
Volume 16, Issue 10, Pages 864-870

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.micinf.2014.08.005

Keywords

CCL20; CCR6; Transcriptional regulation

Funding

  1. Natural Science Foundation of China [81300371, 81370176]
  2. Ministry of Education of China [NCET-12-0484]
  3. Natural Science Foundation of Zhejiang Province [LR12H01003]
  4. Science and Technology Department of Zhejiang Province [2012C33017]
  5. Health Department of Zhejiang Province [201342966]

Ask authors/readers for more resources

Chemokines are key mediators of leukocyte recruitment during immunoregulatory and proinflammatory responses. CCL20 is a cysteine cysteine chemokine that was originally shown to be chemotactic for immature dendritic cells, effector or memory CD4(+) T lymphocytes, and B lymphocytes. Additionally, CCL20 and its only receptor (CCR6) are exploited by cancer cells for migration and metastatic spread and play important roles in the development and progression of cancer. However, it still remains unclear how the activity of the CCL20/CCR6 axis is controlled and regulated at the transcriptional level. The CCL20 promoter region contains a transcription start site, a nuclear factor (NF)-kappa B binding site, a CCAAT/enhancer-binding proteins binding site, an activator protein-1 binding sites, and a specificity protein 1 (Sp1)-binding site. In this review, we outline recent advances in our understanding of the structure of the CCL20 promoter region and discuss the transcriptional regulation of the CCL20 promoter. (C) 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available